Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00201253 · ClinicalTrials.gov registry record
Expression of Tuberculosis in the Lung
A clinical trial of Tuberculosis, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- 40
- Enrollment target
- 2
- Study locations
NCT00201253 is a study of Tuberculosis that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 40 participants, below the 933-participant average among 29 other Tuberculosis trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00201253, a study of Tuberculosis, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess lung immune responses in patients with active pulmonary tuberculosis (TB) and in healthy control persons who are exposed to Mycobacterium tuberculosis in households of patients with TB or who are unexposed.
Conditions Studied
Interventions
- OTHER Bronchoalveolar lavages and venipunctures only
Study Locations (2)
New Jersey
- UMDNJ-New Jersey Medical School - Newark
Other
- Instituto Nacional de Enfermedades Respiratorias (INER) - Mexico City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2000-09 |
| Est. Completion | 2008-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00201253
The ClinicalTrials.gov registry entry for NCT00201253 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 933-participant average among 29 other Tuberculosis trials with a reported enrollment target (96% lower). The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tuberculosis appearing as the primary indexed condition, and to 1 intervention - of which Bronchoalveolar lavages and venipunctures only is the first listed.
NCT00201253 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Other.
Frequently Asked Questions
What is clinical trial NCT00201253 about?
NCT00201253 is a clinical study titled "Expression of Tuberculosis in the Lung". The purpose of this study is to assess lung immune responses in patients with active pulmonary tuberculosis (TB) and in healthy control persons who are exposed to Mycobacterium tuberculosis in households of patients with TB or who are unexposed.
What is the current status of trial NCT00201253?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2000-09. Estimated completion is 2008-06.
What conditions does trial NCT00201253 study?
This clinical trial studies the following conditions: Tuberculosis.
What interventions are being tested in trial NCT00201253?
The interventions under investigation include: Bronchoalveolar lavages and venipunctures only (OTHER).
Who is sponsoring clinical trial NCT00201253?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00201253 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tuberculosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Training Protocol on the Natural History of Tuberculosis
RECRUITING
-
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
RECRUITING
-
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
ACTIVE NOT RECRUITING
-
Gene Expression in HIV and Tuberculosis Co-infection
COMPLETED
-
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
COMPLETED · Phase 1
-
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.